Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages via Induced Anti-inflammatory Cytokines
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background: Chronic low grade inflammation is closely linked to type II diabetes, obesity, and atherosclerosis. Macrophages play a key role in the regulation of pro- or anti- inflammatory actions at the lesion sites of disease. Components of cordyceps militaris, cordycepin and adenosine, have been used for the modulation of inflammatory diseases. The effects of cordycepin in the modulation of macrophages have yet to be be elucidated. We investigated the effects of cordycepin and adenosine on the morphological changes of macrophages under the inflammatory condition of LPS and an anti-inflammatory condition involving high concentrations of adenosine. Methods: We confirmed the mRNA levels of the M1/M2 cytokine genes through RT-PCR and morphological change. Results: LPS-activated macrophages returned to their inactivated original shape, i.e., they looked like naïve macrophages, through the treatment with high concentrations of cordycepin (40 μg/ml). LPS and adenosine activated macrophages also returned to their original inactivated shapes after cordycepin treatment; however, at relatively higher levels of cordycepin than adenosine. This change did not occur with relatively low concentrations of cordycepin. Adenosine down-regulated the gene expression of M1 cytokines (IL-1β, TNF-α) and chemokines (CX3CR1, RANTES), such as cordycepin. Additionally, M2 cytokines (IL-10, IL-1ra, TGF-β) were up-regulated by both cordycepin and adenosine. Conclusion: Based on these observations, both cordycepin and adenosine regulated the phenotypic switch on macrophages and suggested that cordycepin and adenosine may potentially be used as immunomodulatory agents in the treatment of inflammatory disease.
Abstract
Background: Chronic low grade inflammation is closely linked to type II diabetes, obesity, and atherosclerosis. Macrophages play a key role in the regulation of pro- or anti- inflammatory actions at the lesion sites of disease. Components of cordyceps militaris, cordycepin and adenosine, have been used for the modulation of inflammatory diseases. The effects of cordycepin in the modulation of macrophages have yet to be be elucidated. We investigated the effects of cordycepin and adenosine on the morphological changes of macrophages under the inflammatory condition of LPS and an anti-inflammatory condition involving high concentrations of adenosine. Methods: We confirmed the mRNA levels of the M1/M2 cytokine genes through RT-PCR and morphological change. Results: LPS-activated macrophages returned to their inactivated original shape, i.e., they looked like naïve macrophages, through the treatment with high concentrations of cordycepin (40 μg/ml). LPS and adenosine activated macrophages also returned to their original inactivated shapes after cordycepin treatment; however, at relatively higher levels of cordycepin than adenosine. This change did not occur with relatively low concentrations of cordycepin. Adenosine down-regulated the gene expression of M1 cytokines (IL-1β, TNF-α) and chemokines (CX3CR1, RANTES), such as cordycepin. Additionally, M2 cytokines (IL-10, IL-1ra, TGF-β) were up-regulated by both cordycepin and adenosine. Conclusion: Based on these observations, both cordycepin and adenosine regulated the phenotypic switch on macrophages and suggested that cordycepin and adenosine may potentially be used as immunomodulatory agents in the treatment of inflammatory disease.
참고문헌 (18)
- Duncan BB, "Atherosclerosis Risk in Communities Study: Low-grade systemic inflammation and the development of type 2 diabetes:the atherosclerosis risk in communities study", Diabetes, 52, pp.1799~1805 (2003)
- Jacobs M, "Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease:the CODAM study", Eur J Clin Invest, 39, pp.437~444 (2009)
- Gregory JL, "Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2", J Immunol, 177, pp.8072~8079 (2006)
- Schober A, "Chemokine-like functions of MIF in atherosclerosis", J Mol Med, 86, pp.761~770 (2008)
- Mantovani A, "New vistas on macrophage differentiation and activation", Eur J Immunol, 37, pp.14~16 (2007)
- Meghari S, "Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection", Eur J Immunol, 37, pp.24~32 (2007)
- Sugar AM, "Antifungal activity of 3’-deoxyadenosine (cordycepin)", Antimicrob Agents Chemother, 42, pp.1424~1427 (1998)
- Trigg PI, "The effects of cordycepin on malaria parasites", Trans R Soc Trop Med Hyg, 65, pp.514~520 (1971)
- de Julian-Ortiz JV, "Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds", J Med Chem, 42, pp.3308~3314 (1999)
- Deitch AD, "Effects of cordycepin on microtubules of cultured mammalian cells", Exp Cell Res, 118, pp.1~13 (1979)
- Yun Y, "Anti-diabetic Effects of CCCA, CMESS, and Cordycepin from Cordyceps militaris and the Immune Responses in Streptozotocin-induced Diabetic Mice", Natural Product Sciences, 9(4), pp.291~298 (2003), 한국생약학회
- Ralevic V, "Receptors for purines and pyrimidines", Pharmacol Rev, 50, pp.413~492 (1998)
- Fredholm BB, "International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors", Pharmacol Rev, 53, pp.527~552 (2001)
- Drury AN, "The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart", J Physiol, 68, pp.213~237 (1929)
- Mosser DM, "The many faces of macrophage activation", J Leukoce Biol, 73, pp.209~212 (2003)
- Haddad JJ, "Chemioxyexcitation (delta pO2", ROS)-dependent release of IL-1 beta, IL-6 and TNF-alpha: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium, 2001, pp.13, 138~147
- 신슬미, "Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Lipopolysaccharide-induced Inflammation in Macrophages", Immune Network, 9(3), pp.98~105 (2009), 대한면역학회
- Kim HG, "Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-κB through Akt and p38 inhibition in RAW 264.7 macrophage cells", Eur J Pharmacol, 545, pp.192~199 (2006)